STANAG 2242 : 2005
Withdrawn
Withdrawn
POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS
Published date
01-01-2005
Publisher
Withdrawn date
03-24-2023
Sorry this product is not available in your region.
Purpose of this agreement is to develop a unified approach in NATO doctrine and policy in the use of chemoprophylaxis and immunotherapy by NATO personnel against Biological Warfare (BW) agents that cause infectious disease.
| DocumentType |
Standard
|
| PublisherName |
NATO
|
| Status |
Withdrawn
|
| AMEDP-4.1 : 2017 | DEPLOYMENT HEALTH SURVEILLANCE |
| AMEDP-7.6 : A2018 | COMMANDER'S GUIDE ON MEDICAL SUPPORT TO CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR (CBRN) DEFENSIVE OPERATIONS |
| AMEDP-6 VOL 2 : C | NATO HANDBOOK ON THE MEDICAL ASPECTS OF NBC DEFENSIVE OPERATIONS (BIOLOGICAL) |
| STANAG 2535 : 2014 | DEPLOYMENT HEALTH SURVEILLANCE |
| AJMEDP-4 : 2011 | ALLIED JOINT MEDICAL FORCE HEALTH PROTECTION DOCTRINE |
| AMEDP-1.6 : 2016 | MEDICAL EVALUATION MANUAL |
| STANAG 2954 : 2016 | TRAINING OF MEDICAL PERSONNEL FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR (CBRN) DEFENCE |
| STANAG 2478 : 2006 | MEDICAL SUPPORT PLANNING FOR NUCLEAR, BIOLOGICAL AND CHEMICAL ENVIRONMENTS |
| STANAG 2462 : 2005 | NATO HANDBOOK ON THE MEDICAL ASPECTS OF NBC DEFENSIVE OPERATIONS (BIOLOGICAL) - AMEDP-6(C) VOLUME 2 |
| STANAG 2491 : 2003 | POLICY FOR THE IMMUNIZATION OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS |
| STANAG 2873 : 2003 | COMMANDER'S GUIDE ON MEDICAL SUPPORT TO CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND NUCLEAR (CBRN) DEFENSIVE OPERATIONS |
Summarise
Sorry this product is not available in your region.